CIDRAP newsletters options
In Europe's growing third surge, more nations report single-day highs, including Portugal and the Czech Republic.
Interviews with policymakers and antimicrobial resistance (AMR) experts from 13 countries indicate broad support for financial incentives to boost antibiotic development, despite uncertainty over which incentives are appropriate and how much they'll cost, according to a policy brief released yesterday by the European Union Joint Action Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) and the Glob
In a US study published today in Science, researchers detected immune memory to SARS-CoV-2 across all immune cell types studied for as long as 8 months after patients became ill with COVID-19.
The agency says it was disappointed with China over visa problems for the international joint mission and that the B117 variant has been found in 40 nations.
Antibody testing shows that 14% of Americans had been infected by Nov 15, and 35% of deaths were missed.
Georgia is the 5th state to report a B117 variant case, and San Diego County confirms 28 more variant cases.
A rapid review and meta-analysis of studies involving more than 35,000 COVID-19 patients has found that three-quarters received antibiotics even though fewer than 10% had a bacterial co-infection, Canadian researchers reported today in Clinical Microbiology and Infection.
Also, Florida and New York confirm their first cases involving the UK variant.
"Hospitals are becoming overwhelmed with more patients than can be managed with typical care standards."
The country's third lockdown will last till at least mid-February.
Impaired cognition and physical impairment were both tied to higher death rates.
The phase 3 clinical studies indicate good safety, efficacy for both Moderna and Pfizer vaccines.
A new study by researchers from the Centers for Disease Control and Prevention (CDC) shows a substantial decrease in the number of outpatients who received antibiotic prescriptions during the first 5 months of 2020 compared with previous years.
Interim study results published late last week in Morbidity and Mortality Weekly Report (MMWR) found that only 19% of people exposed to a COVID-19 patient in their home who had no symptoms nor a positive test result in the first 7 days of the patient's illness later tested positive—lending support for recently changed Centers for Disease Control and Prevention (CDC) guidelines.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Dec 30
Faced with azithromycin shortages, researchers found the clarithromycin substitute decreases endometritis.
On top of general hesitancy, vaccine attitudes reflected concerns about government interference in the process, including with scientific evaluation.
UK vaccine advisors also recommend 12 week intervals between doses of both vaccines to protect more people with initial doses.
As labs rush to determine variant prevalence, the CDC warns it could put more pressure on US hospitals.
An Italian study in the Journal of Antimicrobial Chemotherapy yesterday found that 21.9% of hospitalized COVID-19 patients acquired bacterial or fungal superinfections—infection by a secondary pathogen—that complicated the course of their recovery.
